Omega-3 supplements lowered enzyme mass, while activity results remained uncertain
A trial meta-analysis found different results for the amount and activity of Lp-PLA2, a circulating enzyme. The abstract does not establish a benefit for cardiovascular events.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The trials found a reduction in the measured amount of Lp-PLA2 with omega-3 supplementation, but the activity result was statistically inconclusive. These are separate laboratory outcomes. This abstract therefore supports a finding about a blood marker; it does not show that participants had fewer heart attacks or other cardiovascular events.
The abstract does not describe participant characteristics, treatment durations, or comparison treatments. Its laboratory endpoints cannot establish the clinical significance of the observed change in marker amount.
What researchers found
Lp-PLA2 mass: weighted mean difference
Omega-3 intervention versus unspecified trial comparators; timeframe not reported. 95% CI -27.63 to -20.47.
The question behind the marker
Earlier studies disagreed about whether supplementation changed this marker. The review separated mass, the amount present, from activity, the enzyme's measured action, rather than treating them as interchangeable measures.
Reading the mixed result
The activity estimate was not statistically significant, so it does not establish that activity was unchanged. Separate analyses also reported lower marker mass for different formulations, without establishing which formulation worked better.
The original publication
Impact of omega-3 supplementation on lipoprotein-associated phospholipase A2 mass and activity: A systematic review and meta-analysis of randomized controlled trials.
Simental-Mendía LE, Simental-Mendía M, Barragán-Zúñiga LJ et al.
J Clin Lipidol · 2026
- PubMed ID
- 41545244
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.